Researchers at the University of Kentucky are studying how elements of our natural surroundings can be potential risk factors for Alzheimer’s disease — including chemicals widely used in plastics.
A new University of Kentucky Markey Cancer Center study published in JCO Precision Oncology demonstrates a feasible way to expand germline genetic testing for patients with cancer.
A study by a team of researchers across the country is the first to demonstrate a connection between the characteristics of patients receiving buprenorphine for opioid use disorder and the use of urine drug testing.
UK and its partners at four other institutions have been awarded $12 million from the National Institutes of Health to launch a new hub focused on accelerating real-world impact of biomedical innovations through education, mentorship and financial support.
Bjoern Bauer, Ph.D., professor in the Department of Pharmaceutical Sciences in the University of Kentucky College of Pharmacy, is one of 16 University Research Professors for 2023-24.
Linda Dwoskin, Ph.D., was invited to Chicago May 9-10 to pitch her startup MUDRx after advancing through two earlier tiers of the review process to the Top 10 of the Best of the BioMidwest competition.
The Foundation for Opioid Response Efforts (FORE) has selected the University of Kentucky College of Pharmacy as one of three higher education entities funded to improve access to medications for opioid use disorder in pharmacies and health care settings.
